or Try an Advanced Search...

    Technical Analysis for PASG - Passage Bio, Inc.

    Grade Last Price % Change Price Change
    B 1.25 1.63% 0.02
    PASG closed down 8.21 percent on Monday, April 15, 2024, on 24 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical PASG trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 1.63%
    Fell Below 50 DMA Bearish 1.63%
    Lower Bollinger Band Touch Weakness 1.63%
    20 DMA Resistance Bearish -6.72%
    50 DMA Support Bullish -6.72%
    20 DMA Resistance Bearish -8.09%
    Crossed Above 50 DMA Bullish -8.09%
    Gapped Up Strength -8.09%
    Fell Below 50 DMA Bearish -0.79%
    Down 3 Days in a Row Weakness -0.79%
    Older End-of-Day Signals for PASG ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 4 hours ago
    Up 3% about 4 hours ago
    Up 2% about 4 hours ago
    Up 1% about 4 hours ago
    Down 5% about 24 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PASG Chart by TradingView
    Basic chart:

    Profile

    Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Organ Systems Rare Diseases Central Nervous System Disorders Nervous System Disorders Lipid Storage Disorders Monogenic Medicine Products Gm1 Rare Tadataka Yamada

    Is PASG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 5 Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program
    Mar 4 Passage Bio files for $200M mixed shelf offering
    Mar 4 Passage Bio GAAP EPS of -$1.86 beats by $0.04
    Mar 4 Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
    Feb 27 Passage Bio to Participate in Upcoming Investor Conferences
    Feb 12 We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully
    Jan 31 Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
    Dec 20 Passage Bio stock climbs 9% on dementia study, program update
    Dec 20 Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
    Nov 13 Passage Bio GAAP EPS of -$0.49 misses by $0.03
    See more PASG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.79
    52 Week Low 0.5751
    Average Volume 408,992
    200-Day Moving Average 0.93
    50-Day Moving Average 1.34
    20-Day Moving Average 1.35
    10-Day Moving Average 1.33
    Average True Range 0.14
    RSI (14) 42.86
    ADX 19.41
    +DI 14.00
    -DI 20.55
    Chandelier Exit (Long, 3 ATRs) 1.27
    Chandelier Exit (Short, 3 ATRs) 1.57
    Upper Bollinger Bands 1.49
    Lower Bollinger Band 1.22
    Percent B (%b) 0.03
    BandWidth 19.75
    MACD Line -0.02
    MACD Signal Line 0.00
    MACD Histogram -0.0134
    Fundamentals Value
    Market Cap 67.43 Million
    Num Shares 54.8 Million
    EPS -2.05
    Price-to-Earnings (P/E) Ratio -0.60
    Price-to-Sales 0.00
    Price-to-Book 0.43
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.45
    Resistance 3 (R3) 1.48 1.42 1.42
    Resistance 2 (R2) 1.42 1.37 1.41 1.40
    Resistance 1 (R1) 1.33 1.33 1.30 1.30 1.39
    Pivot Point 1.27 1.27 1.26 1.26 1.27
    Support 1 (S1) 1.18 1.22 1.15 1.16 1.07
    Support 2 (S2) 1.12 1.18 1.11 1.06
    Support 3 (S3) 1.03 1.12 1.04
    Support 4 (S4) 1.01